Showing improvement on memory or reasoning tests, but no longer necessarily in daily functioning, could lead to approvals.

Excerpt from:
F.D.A. to Ease Alzheimer’s Drug Approval Rules
|
|
|||
|
F.D.A. to Ease Alzheimer’s Drug Approval RulesBy By GINA KOLATA, on March 14th, 2013 Showing improvement on memory or reasoning tests, but no longer necessarily in daily functioning, could lead to approvals.
Excerpt from: Share this:March 14th, 2013 | Tags: alzheimer's disease, border, Clinical trials, drugs (pharmaceuticals), lead, memory, ppr, rove | Category: Alzheimer's Disease, border, Clinical Trials, Drugs (Pharmaceuticals), GE, GI, Lead, Memory, Men, News, PPR, research, Rove, TI, UN, Va Comments are closed. |
America, Inc. at it’s Finest
|
|
|
heave-ho.org Copyright © 2013 heave-ho.org | all the news that's fit to click™ - All Rights Reserved Powered by WordPress & Atahualpa |
|||